Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Oversight Of Medical Products Remains A "High-Risk" Concern For GAO

Apr 11 2011

Related Content

FDA Long-Term Globalization Strategy Under Development

Feb 14 2011

GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products

Jan 26 2009

GAO Report On 510(k) Program Calls For Regulations On 20 Device Types

Jan 19 2009

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window